About InSphero
InSphero is a company based in Schlieren (Switzerland) founded in 2009.. InSphero has raised $35.02 million across 10 funding rounds from investors including ZEISS, Zurcher Kantonalbank and European Union. InSphero offers products and services including Akura Microplate Technology, Akura Organ-on-Chip Technology, and 3D InSight Liver Microtissues. InSphero operates in a competitive market with competitors including Newcells Biotech, Pandorum, Vivodyne, NextVivo and Adapsyn, among others.
- Headquarter Schlieren, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$35.02 M (USD)
in 10 rounds
-
Latest Funding Round
-
Investors
ZEISS
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InSphero
InSphero offers a comprehensive portfolio of products and services, including Akura Microplate Technology, Akura Organ-on-Chip Technology, and 3D InSight Liver Microtissues. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables automated 3D cell culture for drug screening
Simulates human organs for advanced drug testing
Provides 3D liver models for toxicity and safety assessments
Unlock access to complete
Funding Insights of InSphero
InSphero has successfully raised a total of $35.02M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(01 Jun 2009)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series D - InSphero | Valuation | ZEISS |
|
| Jun, 2020 | Amount | Grant - InSphero | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - InSphero | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InSphero
InSphero has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include ZEISS, Zurcher Kantonalbank and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Startup acceleration programs are operated across sectors to support growth.
|
Founded Year | Domain | Location | |
|
Early-stage investments are directed toward ICT and health tech startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InSphero
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InSphero
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Insphero Comparisons
Competitors of InSphero
InSphero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, Pandorum, Vivodyne, NextVivo and Adapsyn, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based platform for lab-grown human tissues
|
|
| domain | founded_year | HQ Location |
Immune-competent human-derived models are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Insphero
Frequently Asked Questions about InSphero
When was InSphero founded?
InSphero was founded in 2009.
Where is InSphero located?
InSphero is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
Is InSphero a funded company?
InSphero is a funded company, having raised a total of $35.02M across 10 funding rounds to date. The company's 1st funding round was a Grant of $56.09K, raised on Jun 01, 2009.
What does InSphero do?
InSphero was founded in 2009 in Schlieren, Switzerland, within the biotechnology sector. Organotypic 3D microtissues are produced for applications in biochemical compound screening and predictive drug testing. Services encompass compound toxicity testing, cell invasion assays, and interactions involving cells and extracellular matrices. Focus areas include metabolic diseases, oncology, and liver diseases, with offerings such as human prostate and mammary carcinoma, alongside rat liver microtissues.
Who are the top competitors of InSphero?
InSphero's top competitors include Newcells Biotech, Vivodyne and Parallel Bio.
What products or services does InSphero offer?
InSphero offers Akura Microplate Technology, Akura Organ-on-Chip Technology, and 3D InSight Liver Microtissues.
Who are InSphero's investors?
InSphero has 8 investors. Key investors include ZEISS, Zurcher Kantonalbank, European Union, EIC Fund, and Jürg Gysi.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.